Latest Biovest Stories

2014-06-16 12:29:42

LONDON, June 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Vaccine Partnering Terms and Agreementshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/cancer_vaccine_partnering_terms_agreements_1.html The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer vaccine partnering...

2008-10-31 03:00:16

Biovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, has executed a distribution agreement with Idis, a European drug distributor, to exclusively supply BiovaxID, a personalized, anti-idiotype cancer vaccine, under a named-patient program in France, Germany, Italy, Greece, Spain and the UK. Under the terms of this agreement, sales of BiovaxID are expected to commence in the first calendar quarter of 2009, with the anticancer vaccine being made available to...

Word of the Day
  • Boughs or branches.
  • Warbling of birds in trees.